Steward Partners Investment Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Hold |
16,161
| – | – | 0.01% | 838 |
|
|
2025
Q1 | $1.47M | Sell |
16,161
-5,577
| -26% | -$508K | 0.01% | 774 |
|
|
2024
Q4 | $1.88M | Buy |
21,738
+14,908
| +218% | +$1.29M | 0.02% | 663 |
|
|
2024
Q3 | $649K | Buy |
6,830
+504
| +8% | +$47.9K | 0.01% | 1009 |
|
|
2024
Q2 | $579K | Sell |
6,326
-145
| -2% | -$13.3K | 0.01% | 1002 |
|
|
2024
Q1 | $587K | Sell |
6,471
-825
| -11% | -$74.8K | 0.01% | 991 |
|
|
2023
Q4 | $594K | Buy |
7,296
+185
| +3% | +$15.1K | 0.01% | 923 |
|
|
2023
Q3 | $568K | Sell |
7,111
-2,006
| -22% | -$160K | 0.01% | 876 |
|
|
2023
Q2 | $718K | Buy |
9,117
+9,037
| +11,296% | +$712K | 0.01% | 806 |
|
|
2023
Q1 | $6.21K | Hold |
80
| – | – | ﹤0.01% | 2711 |
|
|
2022
Q4 | $6.22K | Hold |
80
| – | – | ﹤0.01% | 2690 |
|
|
2022
Q3 | $5K | Hold |
80
| – | – | ﹤0.01% | 2778 |
|
|
2022
Q2 | $6K | Hold |
80
| – | – | ﹤0.01% | 2710 |
|
|
2022
Q1 | $6K | Hold |
80
| – | – | ﹤0.01% | 2842 |
|
|
2021
Q4 | $6K | Hold |
80
| – | – | ﹤0.01% | 2778 |
|
|
2021
Q3 | $6K | Hold |
80
| – | – | ﹤0.01% | 2764 |
|
|
2021
Q2 | $6K | Hold |
80
| – | – | ﹤0.01% | 6439 |
|
|
2021
Q1 | $5.52K | Hold |
80
| – | – | ﹤0.01% | 2988 |
|
|
2020
Q4 | $5K | Hold |
80
| – | – | ﹤0.01% | 2525 |
|
|
2020
Q3 | $5K | Buy |
+80
| New | +$5K | ﹤0.01% | 2380 |
|